Quanterix

We’re thrilled to partner with Diagnostica Longwood and IDIBELL for an exciting event! Join us at "Revolutionizing Biopharma: Breaking Barriers in Biomarker Detection and Single-Cell Imaging with SIMOA & CosMx" on November 12th, 2024. Explore the latest innovations in diagnostics and treatment of neurological diseases with leading experts in the field. Don’t miss the opportunity to dive deep into cutting-edge solutions shaping the future of biopharma. 🗓 Date: November 12, 2024 🕘 Time: 9:00 AM - 3:00 PM CET 📍 Location: IDIBELL Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain. https://bit.ly/40jjju5 #Biopharma #Neurology #BiomarkerDetection #Diagnostics

Quanterix is excited to be at the 2nd Annual Fluid & Imaging Biomarkers & Endpoints in Neuroscience Summit 2024 in Boston! Yesterday, we were thrilled to hear Kelly Miller, Ph.D. present on "Ultrasensitive Biomarkers for Neurodegenerative Disease." Our team, including Kelly R. Miller, Ph.D., Feng Li, and Carly Trulock-Quinn, is here today and eager to connect with you! Come find us to learn how we're advancing neurodegenerative and neuroinflammatory biomarker detection. #Biomarkers #Neuroscience #Neurodegeneration #Neurotherapeutics

🚨 Job Alert! Quanterix is hiring a Vice President of Engineering in Billerica, MA. Join us to lead groundbreaking work in biomarker detection and precision health. Learn more and apply today. ⬇️ #Hiring #VPEngineering #JobOpportunity #JoinUs

We're excited to announce our upcoming 2-day, in-person EU Simoa® Success Seminar in Budapest on November 7-8 at the Crowne Plaza! 🇭🇺 Join us for technical presentations, interactive workshops, and networking opportunities with experts driving research with biomarker detection. Gain a unique opportunity to: ➡️ Learn about the latest advancements in Simoa® technology ➡️ Hear insights from esteemed experts like Aleksandra Maleska Maceski on large-scale NfL and GFAP studies, and Marta Truffi on extracellular vesicle detection in patient plasma ➡️ Dive into cutting-edge research on IFN Subtypes with Mathieu Paul Roder and more! Register today: https://bit.ly/3BSLohA #Biomarkers #Simoa #Quanterix #Networking #ClinicalResearch #Budapest, University Hospital Basel, ICS Maugeri SpA Società Benefit, Université Paris Cité

From Chicago to Houston, from neurology to oncology, from #Neuroscience2024 to #SITC24—let’s reflect on where we’ve been and where we’re headed! This month, we joined global scientists at Neuroscience 2024 in Chicago to explore the latest advancements in neurology. Up next, our team will be in Houston for the Society for Immunotherapy of Cancer (SITC)’s 39th annual meeting. Join us November 6-10 for the world’s largest cancer immunotherapy conference, and visit our team to discover how Quanterix’s Simoa® Technology is transforming cancer research with unmatched biomarker detection. See you at us at booth #817! #SfN2024 #Oncology #CancerResearch #Immunotherapy

The ability to detect oncology protein biomarkers at ultra-low levels can enable new options for diagnostics and treatment in cancer research. Analyzing oncology biomarkers may help monitor cancer risk, identify early-stage cancers, discriminate between benign and malignant cancer types, and stratify patients for targeted therapies. Insights from oncology biomarkers can also be used prognostically to monitor treatment response and cancer recurrence, and predict survival. View our curated list of Simoa® assays for oncology biomarkers that have been developed using the easy-to-use Simoa® homebrew solution for oncology research: https://bit.ly/3UiiLAW #CancerResearch #Oncology #Biomarkers #DiagnosticResearch

We’ve got two exciting new webinars coming up in November in partnership with Springer Nature and SelectScience®! Learn more about our speakers and the groundbreaking research being presented. Don’t miss the chance to engage with leaders in the field of biomarkers and diagnostics. ⬇️ 𝗡𝗲𝘂𝗿𝗼𝗳𝗶𝗹𝗮𝗺𝗲𝗻𝘁 𝗹𝗶𝗴𝗵𝘁 𝗰𝗵𝗮𝗶𝗻 (𝗡𝗳𝗟) 𝗮𝘀 𝗮 𝗯𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝗳𝗼𝗿 𝗰𝗵𝗲𝗺𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝘆-𝗶𝗻𝗱𝘂𝗰𝗲𝗱 𝗽𝗲𝗿𝗶𝗽𝗵𝗲𝗿𝗮𝗹 𝗻𝗲𝘂𝗿𝗼𝗽𝗮𝘁𝗵𝘆 📅 Date: Wednesday, 6 November 2024 🕒 Time: 6:00 PST | 9:00 EST | 14:00 GMT | 15:00 CET Hosted by Springer Nature and led by Tore B. Stage from the Syddansk Universitet - University of Southern Denmark, this session will dive into the role of NfL as a biomarker in detecting neurotoxicity and its potential for identifying chemotherapy-induced peripheral neuropathy (CIPN). NfL technology, developed by Quanterix, enables highly sensitive detection—join us to explore its clinical implications! The webinar will be moderated by Nikki Forrester, Science Writer for Springer Nature. 🖥️ Register now: https://bit.ly/3NtUbca 𝗕𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗕𝗮𝗿𝗿𝗶𝗲𝗿𝘀 𝗶𝗻 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀: 𝗘𝘅𝗽𝗮𝗻𝗱𝗶𝗻𝗴 𝗔𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝗘𝗮𝗿𝗹𝘆 𝗗𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗜𝗺𝗺𝘂𝗻𝗼𝗮𝘀𝘀𝗮𝘆𝘀 📅 Date: Monday, November 14, 2024 🕒 Time: 8:00 PST | 11:00 EST | 15:00 GMT | 16:00 CET Hosted by SelectScience®, this session features Dr. Laia Montoliu Gaya from the University of Gothenburg, a leader in the development of Simoa assays for Alzheimer's disease. She will discuss recent advancements in diagnostic biomarkers and explore how innovations like blood-based biomarker collection systems are expanding access to broader populations. This is a must-attend for anyone interested in the future of Alzheimer's diagnosis and treatment. 🖥️ Register now: https://bit.ly/4fsluQr #Webinar #Neuroscience #Alzheimers #Biomarkers

Cutting-edge technologies like at-home amyloid tests, minimally-invasive blood assays, and circulating tumor DNA tests are revolutionizing personalized health care—enabling earlier detection of diseases like Alzheimer’s and cancer, and tailoring treatments to individual patients. Download the free e-book from STAT to uncover the technological breakthroughs shaping the future of health care, from innovative liquid biopsies to functional precision medicine, and how these advancements are accelerating the fight against some of the world’s most complex diseases. https://bit.ly/3zLUBHX #PrecisionMedicine #GeneticSequencing #CancerResearch #AlzheimersResearch

Did you miss our live webinar? The recording is now available on-demand. Discover how biomarker testing is revolutionizing clinical trials and enabling early disease detection in key areas such as neurology, oncology, and immunology. In this session, led by Mingwei Zhao, Senior Director of Lab Services at Quanterix, you’ll gain insights into cutting-edge biomarker technologies and learn how they’re advancing disease management. 🖥️ Watch the recording here: https://bit.ly/4de0paU #Biomarkers #ClinicalResearch #Webinar

Today, we celebrate the rich cultures, histories, and contributions of Indigenous peoples. At Quanterix, we recognize the importance of this day and believe in honoring it by giving our employees the day off, allowing us to reflect on the significance of Indigenous heritages and to engage in meaningful discussions about respect, diversity, and inclusion. Let’s take this opportunity to learn, appreciate, and amplify Indigenous voices in our communities. Together, we can build a culture of understanding and respect. 💚 #IndigenousPeoplesDay #Respect #Diversity #Inclusion